Title: Crohn's disease: orofacial considerations and disease pathogenesis
Abstract: Periodontology 2000Volume 6, Issue 1 p. 101-115 Crohn's disease: orofacial considerations and disease pathogenesis John R. Kalmar, John R. KalmarSearch for more papers by this author John R. Kalmar, John R. KalmarSearch for more papers by this author First published: October 1994 https://doi.org/10.1111/j.1600-0757.1994.tb00030.xCitations: 25AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Afdhal NH, Long A, Lennon J, Crowe J, O'Donoghue DP. Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo. Dig Dis Sci 1991: 36: 449–453. 10.1007/BF01298873 PubMedWeb of Science®Google Scholar 2 Ainsworth M, Eriksen J, Rasmussen JW, Schaffalitzky de Muckadell, OB. Intestinal permeability of 51Cr-labeled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989: 24: 993–998. 10.3109/00365528909089246 PubMedWeb of Science®Google Scholar 3 Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992: 127: 25–49. 10.1111/j.1600-065X.1992.tb01407.x CASPubMedWeb of Science®Google Scholar 4 Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993: 54: 1–78. 10.1016/S0065-2776(08)60532-5 CASPubMedWeb of Science®Google Scholar 5 Akuffo HO. Non-parasite-specific cytokine responses may influence disease outcome following infection. Immunol Rev 1992: 127: 51–68. 10.1111/j.1600-065X.1992.tb01408.x CASPubMedWeb of Science®Google Scholar 6 Barnes RM, Allan S, Taylor-Robinson CH, Finn R, Johnson PM. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 1990: 92: 9–15. 10.1159/000235217 CASPubMedWeb of Science®Google Scholar 7 Basu MK, Asquith P. Oral manifestations of inflammatory bowel disease. Clin Gastroenterol 1980: 9: 307–321. 10.1016/S0300-5089(21)00451-X CASPubMedWeb of Science®Google Scholar 8 Basu MK, Asquith P, Thompson RA, Cooke WT. Oral manifestations of Crohn's disease. Gut 1975: 16: 249–254. 10.1136/gut.16.4.249 PubMedWeb of Science®Google Scholar 9 R Berkow, AJ Fletcher, ed. Chronic inflammatory diseases of the bowel; Crohn's disease. In: The Merck manual. 16th edn. Rathway , NJ : Merck Research Laboratories, 1992: 830–834. Google Scholar 10 Bernstein ML, MacDonald JS. Oral lesions in Crohn's disease: report of two cases and update of the literature. Oral Surg Oral Med Oral Pathol 1978: 46: 234–245. 10.1016/0030-4220(78)90198-6 PubMedWeb of Science®Google Scholar 11 Block GE, Michelassi F, Tanaka M, Riddell RH, Hanauer SB. Crohn's disease. Curr Probl Surg 1993: 30: 173–265. 10.1016/0011-3840(93)90035-F CASPubMedWeb of Science®Google Scholar 12 Bloom BR, Salgame P, Diamond B. Revisiting and revising suppressor T cells. Immunol Today 1992: 13: 131–136. 10.1016/0167-5699(92)90110-S CASPubMedWeb of Science®Google Scholar 13 Boraz RA. Oral manifestations of Crohn disease: update of the literature and report of case. J Dent Child 1988: 55: 72–74. CASPubMedWeb of Science®Google Scholar 14 Boughton-Smith NK, Evans SM, Hawkey CJ et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993: 342: 338–340. 10.1016/0140-6736(93)91476-3 CASPubMedWeb of Science®Google Scholar 15 Bourgeois-Droin C, Harvard S, Granier F et al. Granulomatous cheilitis in two children with sarcoidosis. J Am Acad Dermatol 1993: 29: 822–824. 10.1016/0190-9622(93)70246-P CASPubMedWeb of Science®Google Scholar 16 Brook IM, King DJ, Miller ID. Chronic granulomatous cheilitis and its relationship to Crohn's disease. Oral Surg Oral Med Oral Pathol 1983: 56: 405–408. 10.1016/0030-4220(83)90351-1 CASPubMedWeb of Science®Google Scholar 17 Butcher PD, McFadden JJ, Hennon-Taylor J. Investigation of mycobacteria in Crohn's disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn's disease isolated mycobacteria. Gut 1988: 29: 1222–1228. 10.1136/gut.29.9.1222 CASPubMedWeb of Science®Google Scholar 18 Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989: 34: 1841–1854. 10.1007/BF01536701 CASPubMedWeb of Science®Google Scholar 19 Casellas F, Agaudé S, Soriano B, Accarino A, Molero J, Guarner L. Intestinal permeability to 99mTe-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol 1986: 81: 767–770. PubMedWeb of Science®Google Scholar 20 Chess S, Chess D, Olander G, Benner W, Cole WH. Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. Surgery 1950: 27: 221–234. Web of Science®Google Scholar 21 Chess S, Olander G, Puestow CB, Benner W, Chess D. Regional enteritis: clinical and experimental observations. Surg Gynecol Obstet 1950: 91: 343–350. CASPubMedWeb of Science®Google Scholar 22 Cho S-X, Brennan PJ, Yoshimura HH, Korelitz BI, Graham DY. Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis. Gut 1986: 27: 1353–1356. 10.1136/gut.27.11.1353 PubMedWeb of Science®Google Scholar 23 Choy MY, Walker-Smith JA, Williams CB, MacDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lumina in Crohn's disease and ulcerative colitis. Gut 1990: 31: 1365–1370. 10.1136/gut.31.12.1365 CASPubMedWeb of Science®Google Scholar 24 Coenen C, Boersch G, Müller KM, Fabry H. Oral inflammatory changes as an initial manifestation of Crohn's disease antedating abdominal diagnosis. Dis Colon Rectum 1988: 31: 548–552. 10.1007/BF02553730 CASPubMedWeb of Science®Google Scholar 25 RS Cotran, C Kumar, SL Robbins, ed. Crohn's disease (regional enteritis). In: Robbins pathologic basis of disease. 4th edn. Philadelphia : Saunders, 1989: 867–872. Google Scholar 26 Crabtree JE, Juby LD, Heatle RV, Lobo AJ, Bullimore DW, Axon ATR. Soluble interleukin–2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut 1990: 31: 1033–1036. 10.1136/gut.31.9.1033 PubMedWeb of Science®Google Scholar 27 Crama-Bohbouth G, Lems-Van Kan, P, Weterman IT, Biemond I, Pena AS. Immunological findings in whole saliva and parotid saliva of patients with Crohn's disease and healthy controls. Dig Dis Sci 1984: 29: 1089–1092. 10.1007/BF01317081 CASPubMedWeb of Science®Google Scholar 28 Croft CB, Wilkinson AR. Ulceration of the mouth, pharynx and larynx in Crohn's disease of the intestines. Br J Surg 1972: 59: 249–252. 10.1002/bjs.1800590402 PubMedWeb of Science®Google Scholar 29 Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: pathologic and clinical entity. JAMA 1932: 99: 1323. 10.1001/jama.1932.02740680019005 Web of Science®Google Scholar 30 Curran FT, Youngs DJ, Allan RN. Keighley MR. Candidacidal activity of Crohn's disease neutrophils. Gut 1991: 32: 55–60. 10.1136/gut.32.1.55 CASPubMedWeb of Science®Google Scholar 31 Dudeney TP, Todd IP. Crohn's disease of the mouth. Proc R Soc Med 1969: 62: 1237. CASPubMedGoogle Scholar 32 Dyer NH, Cook PL, Kemp-Harper RA. Oesophageal stricture associated with Crohn's disease. Gut 1969: 10: 549–554. 10.1136/gut.10.7.549 CASPubMedWeb of Science®Google Scholar 33 Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins GCF from healthy, gingivitis and periodontitis sites. J Periodont Res 1993: 28: 543–546. 10.1111/j.1600-0765.1993.tb02121.x PubMedWeb of Science®Google Scholar 34 Eisenbud L, Katzka I, Platt N. Oral manifestations in Crohn's disease. Oral Surg Oral Med Oral Pathol 1972: 34: 770–773. 10.1016/0030-4220(72)90294-0 CASPubMedWeb of Science®Google Scholar 35 Ellitsgaard N, Andersson AP. Worsaae N, Medgyesi S. Long-term results after surgical reduction cheiloplasty in patients with Melkersson-Rosenthal syndrome and cheilitis granulomatosa. Ann Plast Surg 1993: 31: 413–420. 10.1097/00000637-199311000-00005 CASPubMedWeb of Science®Google Scholar 36 Elmgreen J, Binder V. The chemotactic function of neutrophils in ulcerative colitis. Scand J Gastroenterol 1982: 17: 561–564. 10.3109/00365528209182250 CASPubMedWeb of Science®Google Scholar 37 Engel LD, Pasquinelli KL, Leone SA, Moncla BJ, Nielson KD, Rabinovitch PS. Abnormal lymphocyte profiles and leukotriene B4 status in a patient with Crohn's disease and severe periodontitis. J Periodontol 1988: 59: 841–847. 10.1902/jop.1988.59.12.841 CASPubMedWeb of Science®Google Scholar 38 Ficarra G, Cicchi P, Amorosi A. Piluso S. Oral Crohn's disease and pyostomatitis vegetans. An unusual association. Oral Surg Oral Med Oral Pathol 1993: 75: 220–224. 10.1016/0030-4220(93)90097-N CASPubMedWeb of Science®Google Scholar 39 Field EA, Tyldesley WR. Oral Crohn's disease revisited-A 10-year-review. Br J Oral Maxillofac Surg 1989: 27: 114–123. 10.1016/0266-4356(89)90058-2 CASPubMedWeb of Science®Google Scholar 40 Flemming TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. J Clin Periodontol 1991: 18: 690–697. 10.1111/j.1600-051X.1991.tb00111.x PubMedWeb of Science®Google Scholar 41 Forman L. Two cases of pyodermite végétante (Hallopeau): an eosinophilic pustular and vegetating dermatitis with conjunctival, oral and colonic involvement. Proc R Soc Med 1965: 58: 244–249. 10.1177/003591576505800422 CASPubMedWeb of Science®Google Scholar 42 Franceschi S, Panza E, La Vecchia, C, Parazzini F, Decarli A, Bianchi Porro G. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987: 125: 445–452. 10.1093/oxfordjournals.aje.a114550 CASPubMedWeb of Science®Google Scholar 43 Frankel DH, Mostifi RS, Lorinez AL. Oral Crohn's disease: report of two cases in brothers with metallic dysgeusia and review of the literature. J Am Acad Dermatol 1985: 12: 260–268. 10.1016/S0190-9622(85)80033-5 CASPubMedWeb of Science®Google Scholar 44 Gasche C, Reinisch W, Lochs H, Gangl A. Interleukin–6 production in Crohn's disease. Gastroenterology 1992: 103: 1120–1121. 10.1016/0016-5085(92)90072-7 CASPubMedWeb of Science®Google Scholar 45 Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin–6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993: 64: 980–983. 10.1902/jop.1993.64.10.980 PubMedWeb of Science®Google Scholar 46 Ghandour K, Issa M. Oral Crohn's disease with late intestinal manifestations. Oral Surg Oral Med Oral Pathol 1991: 72: 565–567. 10.1016/0030-4220(91)90495-X CASPubMedWeb of Science®Google Scholar 47 Graham DY, Markesich DC, Yoshimura HH. Mycobacteria and inflammatory bowel disease. Gastroenterology 1987: 92: 436–442. 10.1016/0016-5085(87)90139-9 PubMedWeb of Science®Google Scholar 48 Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol 1992: 26: 371–383. 10.1016/0190-9622(92)70059-O CASPubMedWeb of Science®Google Scholar 49 Greenstein AJ, Janowitz HD. Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976: 55: 401–412. 10.1097/00005792-197609000-00004 PubMedWeb of Science®Google Scholar 50 Gross V, Andus T, Caesar I, Roth M, Scholmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992: 102: 514–519. 10.1016/0016-5085(92)90098-J CASPubMedWeb of Science®Google Scholar 51 Gurbindo C, Sabbah S, Menezes J, Justinich C, Marchand R, Seidman EG. Interleukin–2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis. I Pediatr Gastroenterol Nutr 1993: 17: 247–254. 10.1002/j.1536-4801.1993.tb10963.x CASPubMedWeb of Science®Google Scholar 52 Halme L, Meurman JH, Laine P et al. Oral findings in patients with active or inactive Crohn's disease. Oral Surg Oral Med Oral Pathol 1993: 76: 175–181. 10.1016/0030-4220(93)90200-N CASPubMedWeb of Science®Google Scholar 53 Halme L, Von Smitten, K, Stenman S, Turpeinen U, Stenman UH. Concentrations of pancreatic secretory trypsin inhibitor (PSTI), acute phase proteins, and neopterin in Crohn's disease. Comparison with clinical disease activity and endoscopical findings. Scand J Clin Lab Invest 1993: 53: 359–366. 10.3109/00365519309086628 CASPubMedWeb of Science®Google Scholar 54 Heatley RV, Bolton PM, Hughes LE, Owen EW. Mesenteric lymphatic obstruction in Crohn's disease. Digestion 1980: 20: 307–313. 10.1159/000198452 CASPubMedWeb of Science®Google Scholar 55 Henry CH. Orofacial granulomatosis: report of a case with decreased CD4/CD8 ratio. J Oral Maxillofac Surg 52: 317–322. Google Scholar 56 Hinks LJ, Inwards KD, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol 1988: 41: 198–201. 10.1136/jcp.41.2.198 PubMedWeb of Science®Google Scholar 57 Holdstock G, Savage D, Harman M, Wright R. Should patients with inflammatory bowel disease smoke? Br Med J 1984: 288: 362. 10.1136/bmj.288.6414.362 CASPubMedWeb of Science®Google Scholar 58 Hudson MA, Wakefield AJ, Hutton RA et al. Factor XIII: is it a factor in Crohn's disease? Gastroenterology 1993: 105: 605–607. 10.1016/0016-5085(93)90748-2 PubMedGoogle Scholar 59 Isstoff SW. Some aspects of Crohn's disease (Letter). S Afr Med J 1973: 47: 1676. PubMedWeb of Science®Google Scholar 60 Jacob E, Baker SJ, Swaminathan SP. 'M' cells in the follicle-associated epithelium of the human colon. Histopathology 1987: 11: 941–952. 10.1111/j.1365-2559.1987.tb01900.x CASPubMedWeb of Science®Google Scholar 61 James SP. Remission of Crohn's disease after human immunodeficiency virus infection. Gastroenterology 1988: 95: 1667–1669. 10.1016/S0016-5085(88)80094-5 CASPubMedWeb of Science®Google Scholar 62 Kano Y, Shiohara T, Yagita A, Nagashima M. Granulomatous cheilitis and Crohn's disease. Br J Dermatol 1990: 123: 409–412. 10.1111/j.1365-2133.1990.tb06303.x PubMedWeb of Science®Google Scholar 63 Kano Y, Shiohara T, Yagita A, Nagashima M. Association between cheilitis granulomatosa and Crohn's disease. J Am Acad Dermatol 1993: 28: 801–807. 10.1016/S0190-9622(09)80285-5 CASPubMedWeb of Science®Google Scholar 64 Katschinski B, Logan RF, Edmond M, Langman MJ. Smoking and sugar intake are separate but interactive risk factors in Crohn's disease. Gut 1988: 29: 1202–1206. 10.1136/gut.29.9.1202 CASPubMedWeb of Science®Google Scholar 65 Katz J. Treatment of Crohn's disease with 5-ASA. Am J Gastroenterol 1993: 88: 1315–1317. CASPubMedWeb of Science®Google Scholar 66 Katz KD, Hollander D, Vadheim CM et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989: 97: 927–931. 10.1016/0016-5085(89)91499-6 CASPubMedWeb of Science®Google Scholar 67 Kiechle FL, Malinski T. Nitric oxide. Biochemistry, pathophysiology, and detection. Clin Chem 1993: 100: 567–575. CASPubMedWeb of Science®Google Scholar 68 Kirsner JB. Inflammatory bowel disease. Nature and pathogenesis. Dis Mon 1991: 37: 609–666. 10.1016/0011-5029(91)90024-6 Google Scholar 69 Kirsner JB. Inflammatory bowel disease. Clinical and therapeutic aspects. Dis Mon 1991: 37: 672–746. 10.1016/S0011-5029(05)80013-6 Google Scholar 70 Kono Y, Beagley KW, Fujihashi K et al. Cytokine regulation of localized inflammation. Induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in in flamed human gingiva. J Immunol 1991: 146: 1812–1821. CASPubMedWeb of Science®Google Scholar 71 Kuster W, Pascoe L, Purrmann J, Funk S, Majewski F. The genetics of Crohn's disease: complex segregation analysis of a family study with 265 patients with Crohn's disease and 5,387 relatives. Am J Med Genet 1989: 32: 105–108. 10.1002/ajmg.1320320122 CASPubMedWeb of Science®Google Scholar 72 Kusugami K, Youngman KR, West GA, Fiocchi C. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterol 1989: 97: 1–9. 10.1016/0016-5085(89)91408-X PubMedWeb of Science®Google Scholar 73 Kyle J. Crohn's disease. London : William Heinemann Medical Books Ltd, 1972: 78. Google Scholar 74 Lamster IB, Rodrick ML, Sonis ST, Falchuk ZM. An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease. J Periodontol 1982: 53: 231–238. 10.1902/jop.1982.53.4.231 CASPubMedWeb of Science®Google Scholar 75 Lamster I, Sonis S, Hannigan A, Kolodkin A. An association between Crohn's disease, periodontal disease and enhanced neutrophil function. J Periodontol 1978: 49: 475–479. 10.1902/jop.1978.49.9.475 CASPubMedWeb of Science®Google Scholar 76 Levine J. Exogenous factors in Crohn's disease. A critical review. J Clin Gastroenterol 1992: 14: 216–226. 10.1097/00004836-199204000-00007 CASPubMedWeb of Science®Google Scholar 77 MacDermott RP, Stenson WF. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 1988: 42: 285–328. 10.1016/S0065-2776(08)60848-2 CASPubMedWeb of Science®Google Scholar 78 Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin–6 in active Crohn's disease but not ulcerative colitis. Gut 1991: 32: 1531–1534. 10.1136/gut.32.12.1531 PubMedWeb of Science®Google Scholar 79 Malins TJ, Wilson A, Ward-Booth RP. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol 1991: 72: 19–21. 10.1016/0030-4220(91)90182-C CASPubMedWeb of Science®Google Scholar 80 Marcus R, Watt J. Seaweeds and ulcerative colitis in laboratory animals. Lancet 1969: 2: 489–490. 10.1016/S0140-6736(69)90187-1 CASPubMedWeb of Science®Google Scholar 81 Markesich DC, Sawai ET, Butel JS, Graham DY. Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins. Dig Dis Sci 1991: 36: 454–460. 10.1007/BF01298874 CASPubMedWeb of Science®Google Scholar 82 Mayberry FJ, Rhodes J. Epidemiological aspects of Crohn's disease: a review of the literature. Gut 1984: 25: 886–899. 10.1136/gut.25.8.886 CASPubMedWeb of Science®Google Scholar 83 Mayberry JF, Rhodes J, Newcombe RG. Breakfast and dietary aspects of Crohn's disease. Br Med I 1978: 2: 1401. 10.1136/bmj.2.6149.1401 PubMedWeb of Science®Google Scholar 84 McCarthy FP. Pyostomatitis vegetans. Report of three cases. Arch Dermatol Syphil 1949: 60: 750–764. 10.1001/archderm.1949.01530050112010 CASPubMedWeb of Science®Google Scholar 85 McKenzie H, Main I. Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990: 31: 536–538. 10.1136/gut.31.5.536 PubMedWeb of Science®Google Scholar 86 McPoland PR, Moss RL. Cutaneous Crohn's disease and progressive vitiligo. J Am Acad Dermatol 1988: 19: 421–425. 10.1016/S0190-9622(88)70192-9 CASPubMedWeb of Science®Google Scholar 87 Miller DS, Keighley A, Smith PG, Hughes AO, Langman MJS. A case-control method for seeking evidence of contagion in Crohn's disease. Gastroenterology 1976: 71: 385–387. CASPubMedWeb of Science®Google Scholar 88 Mitsuyama K, Sasaki E, Toyonaga A et al. Colonic mucosal interleukin–6 in inflammatory bowel disease. Digestion 1991: 50: 104–111. 10.1159/000200747 CASPubMedWeb of Science®Google Scholar 89 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991: 43: 109–142. CASPubMedWeb of Science®Google Scholar 90 Monsén U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol 1991: 26: 302–306. 10.3109/00365529109025046 CASPubMedWeb of Science®Google Scholar 91 Munch H, Purrman J, Reis HE et al. Clinical features of inflammatory joint and spine manifestations of Crohn's disease. Hepatogastroenterology 1986: 33: 123–127. CASPubMedWeb of Science®Google Scholar 92 Munkholm P, Langholz E, Davisen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993: 105: 1716–1723. 10.1016/0016-5085(93)91068-S CASPubMedWeb of Science®Google Scholar 93 Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993: 34: 1705–1709. 10.1136/gut.34.12.1705 CASPubMedWeb of Science®Google Scholar 94 Neville BW, Smith SE, Maize JC, Laden SA, Denton WT. Pyostomatitis vegetans. Am J Dermatopathol 1985: 7: 69–77. 10.1097/00000372-198502000-00015 CASPubMedWeb of Science®Google Scholar 95 Olaison G, Leandersson P, Sjödahl R, Tagesson C. Intestinal permeability to polyetheleneglycol 600 in Crohn's disease: preoperative determination in a defined segment of the small intestine. Gut 1988: 29: 196–199. 10.1136/gut.29.2.196 CASPubMedWeb of Science®Google Scholar 96 Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen T, Binder V. Familial occurrence of inflammatory bowel disease. X Engl J Med 1991: 324: 84–88. 10.1056/NEJM199101103240203 PubMedGoogle Scholar 97 Pearson M, Teahon K, Levi Al, Bjarnason I. Food intolerance and Crohn's disease. Gut 1993: 34: 783–787. 10.1136/gut.34.6.783 CASPubMedWeb of Science®Google Scholar 98 Penny WJ, Mayberry JF, Aggett PJ, Gilbert JO, Newcombe RG, Rhodes J. Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut 1983: 24: 288–292. 10.1136/gut.24.4.288 PubMedWeb of Science®Google Scholar 99 Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease: an analysis of 79 cases. J Clin Gastroenterol 1991: 13: 29–37. 10.1097/00004836-199102000-00008 CASPubMedWeb of Science®Google Scholar 100 Podolsky DK. Inflammatory bowel disease. Part II. N Engl J Med 1991: 325: 928–937. 10.1056/NEJM199109263251306 PubMedWeb of Science®Google Scholar 101 Podolsky DK. Inflammatory bowel disease. Part II. N Engl J Med 1991: 325: 1008–1016. 10.1056/NEJM199110033251406 PubMedWeb of Science®Google Scholar 102 Price AB, Morson BC. Inflammatory bowel disease. The surgical pathology of Crohn's disease and ulcerative colitis. Hum Pathol 1975: 6: 7–29. 10.1016/S0046-8177(75)80107-9 CASPubMedWeb of Science®Google Scholar 103 Purrmann J, Bertrams J, Knapp M et al. Gene and haplotype frequencies of HLA antigens in 269 patients with Crohn's disease. Scand J Gastroenterol 1990: 25: 981–985. 10.3109/00365529008997623 PubMedWeb of Science®Google Scholar 104 Purrmann J, Cleveland S, Hengels KJ. Various genetic models in Crohn's disease. Z Gastroenterol 1991: 29: 276–282. CASPubMedWeb of Science®Google Scholar 105 Purrmann J, Zeidler H, Bertrams J et al. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27, B44. J Rheumatol 1988: 15: 1658–1661. CASPubMedWeb of Science®Google Scholar 106 Puzas JE, Hicks DG, Reynolds SD, O'Keefe RJ. Regulation of osteoclastic activity in infection. Methods Enzymol 1994: 236: 47–58. 10.1016/0076-6879(94)36008-1 CASPubMedWeb of Science®Google Scholar 107 Raedler A, Schreiber S, De Weerth A, Voss A, Peters S, Greten H. Assessment of in vivo activated T cells in patients with Crohn's disease. Hepatogastroenterology 1990: 37: 67–71. CASPubMedWeb of Science®Google Scholar 108 Reinhardt RA, Masada, MR Kaidahl, VVB et al. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993: 20: 225–231. 10.1111/j.1600-051X.1993.tb00348.x PubMedWeb of Science®Google Scholar 109 Rhodes JM, Potter BJ, Brown, DIC Jewel, DP Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology 1982: 82: 1327–1334. 10.1016/0016-5085(82)90065-8 PubMedWeb of Science®Google Scholar 110 Rickert RR, Carter WH. The "early" ulcerative lesions of Crohn's disease: Correlative light- and scanning electronmicroscopic studies. J Clin Gastroenterol 1980: 2: 11–19. 10.1097/00004836-198003000-00003 CASPubMedWeb of Science®Google Scholar 111 Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1993: 28: 605–608. 10.3109/00365529309096096 CASPubMedWeb of Science®Google Scholar 112 Riordan AM, Hunter JO, Cowan RE et al. Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre Controlled Trial. Lancet 1993: 342: 1131–1134. 10.1016/0140-6736(93)92121-9 PubMedWeb of Science®Google Scholar 113 Rombeau JL, Afono JJ. Clinical and scientific basis for nutritional support of patients with inflammatory bowel disease. In: RP MacDermott, WF Stenson, ed. Current topics in gastroenterology: inflammatory bowel disease. New York : Elsevier Science Publishing, 1992: 525–553. Google Scholar 114 Roodman DG. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993: 53: S94–S98. 10.1007/BF01673412 CASPubMedWeb of Science®Google Scholar 115 Rooney T. Dental caries prevalence in patients with Crohn's disease. Oral Surg Oral Med Oral Pathol 1984: 57: 623–624. 10.1016/0030-4220(84)90284-6 CASPubMedWeb of Science®Google Scholar 116 Sakuntabhai A, MacLeod RI, Lawrence CM. Intralesional steroid injection after nerve block anesthesia in the treatment of orofacial granulomatosis. Arch Dermatol 1993: 129: 477–480. CASPubMedWeb of Science®Google Scholar 117 Sandler RS, Golden AL. Epidemiology of Crohn's disease. J Clin Gastroenterol 1986: 8: 160–165. 10.1097/00004836-198604000-00011 PubMedWeb of Science®Google Scholar 118 Schiller KFR, Golding PL, Peebles RA. Whitehead R. Crohn's disease of the mouth and lips. Gut 1975: 12: 864–865. PubMedWeb of Science®Google Scholar 119 Schlegel-Gomez R, Özen, IY, Peters K-P. Simon Jr. M, Hornstein O-P. Morbus Crohn-Erstmanifestation im oralen und anogenitalen Bereich. Hautarzt 1989: 40: 451–455. PubMedWeb of Science®Google Scholar 120 Schmidt WU, Sattler J, Hesterberg R et al. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment? Agents Actions 1990: 30: 267–270. 10.1007/BF01969057 CASPubMedWeb of Science®Google Scholar 121 Schnitt SJ, Antonioli DA, Jaffe B, Peppercorn MA. Granulomatous inflammation of minor salivary gland ducts: a new oral manifestation of Crohn's disease. Hum Pathol 1987: 18: 405–407. 10.1016/S0046-8177(87)80175-2 CASPubMedWeb of Science®Google Scholar 122 Schurmann G, Betzler M, Post S, Herfarth C, Meuer S. Soluble interleukin–2 receptor, interleukin–6 and interleukin–1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations. Digestion 1992: 51: 51–59. 10.1159/000200875 CASPubMedWeb of Science®Google Scholar 123 Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Technetium–99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Gut 1993: 34: 1364–1369. 10.1136/gut.34.10.1364 CASPubMedWeb of Science®Google Scholar 124 Scully C, Cochran KM, Russell RI et al. Crohn's disease of the mouth: an indicator of intestinal involvement. Gut 1982: 23: 198–201. 10.1136/gut.23.3.198 CASPubMedWeb of Science®Google Scholar 125 Segal AW, Loewi, G: Neutrophil dysfunction in Crohn's disease. Lancet 1976: 2: 219. 10.1016/S0140-6736(76)91024-2 CASPubMedWeb of Science®Google Scholar 126 Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodont Res 1993: 28: 478–486. 10.1111/j.1600-0765.1993.tb02108.x CASPubMedWeb of Science®Google Scholar 127 Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993: 342: 407–411. 10.1016/0140-6736(93)92818-E CASPubMedWeb of Science®Google Scholar 128 Simpson HE, Summersgill GB, Howell RA. Oral lesions in Crohn's disease. J Oral Med 1976: 31: 67–68. PubMedGoogle Scholar 129 Smolen JS, Gangl A, Poleterauer P, Mayr WR. HLA antigens in inflammatory bowel disease. Gastroenterology 1982: 82: 34–38. 10.1016/0016-5085(82)90119-6 PubMedWeb of Science®Google Scholar 130 Snyder MB, Cawson RA. Oral changes in Crohn's disease. J Oral Surg 1976: 34: 594–597. PubMedWeb of Science®Google Scholar 131 Solis-Herruzo JA, Fernandez B, Vilalta-Castell E et al. Diminished cytochrome b content and toxic oxygen metabolite production in circulating neutrophils from patients with Crohn's disease. Dig Dis Sci 1993: 38: 1631–1637. 10.1007/BF01303171 CASPubMedWeb of Science®Google Scholar 132 Somerville KW, Logan RF, Edmond M, Langman MJ. Smoking and Crohn's disease. Br Med J 1984: 289: 954–956. 10.1136/bmj.289.6450.954 CASPubMedWeb of Science®Google Scholar 133 Stevens C, Walz G, Singaram C et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992: 37: 818–826. 10.1007/BF01300378 CASPubMedWeb of Science®Google Scholar 134 Stowe SP, Redmond SR, Stormont JM et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Gastroenterology 1990: 98: 104–110. 10.1016/0016-5085(90)91297-J CASPubMedWeb of Science®Google Scholar 135 Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn's disease. Lancet 1990: 336: 1096–1097. 10.1016/0140-6736(90)92572-Y CASPubMedWeb of Science®Google Scholar 136 Sundh B, Emilson C-G. Salivary and microbial conditions and dental health in patients with Crohn's disease: a 3-year study. Oral Surg Oral Med Oral Pathol 1989: 67: 286–290. 10.1016/0030-4220(89)90356-3 CASPubMedWeb of Science®Google Scholar 137 Surawicz CM, Meisel JL, Ylvisaker T, Saunders DR, Rubin CE. Rectal biopsy in the diagnosis of Crohn's disease: value of multiple biopsies and serial sectioning. Gastro-enterology 1981: 80: 66–71. PubMedWeb of Science®Google Scholar 138 Sussman GL, Yang WH, Steinberg S. Melkersson-Rosenthal syndrome: clinical, pathologic, and therapeutic considerations. Ann Allergy 1992: 69: 187–194. PubMedWeb of Science®Google Scholar 139 Sutherland LR, Rancharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990: 98: 1123–1128. 10.1016/0016-5085(90)90324-T CASPubMedWeb of Science®Google Scholar 140 Talbot T, Jewell L, Schloss E, Yakimeto W, Thompson ABR. Cheilitis antedating Crohn's disease: case report and literature update of oral lesions. J Clin Gastroenterol 1984: 6: 349–354. CASPubMedWeb of Science®Google Scholar 141 Taylor VE, Smith CJ. Oral manifestations of Crohn's disease without demonstrable gastrointestinal lesions. Oral Surg Oral Med Oral Pathol 1975: 39: 58–66. 10.1016/0030-4220(75)90396-5 PubMedWeb of Science®Google Scholar 142 Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years' experience with an elemental diet in the management of Crohn's disease. Gut 1990: 31: 1133–1137. 10.1136/gut.31.10.1133 CASPubMedWeb of Science®Google Scholar 143 Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992: 33: 320–323. 10.1136/gut.33.3.320 CASPubMedWeb of Science®Google Scholar 144 Tyldesley WR. Oral Crohn's disease and related conditions. Br J Oral Surg 1979: 17: 1–9. 10.1016/0007-117X(79)90001-5 CASPubMedWeb of Science®Google Scholar 145 Tysk C, Lindberg E, Arnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988: 29: 990–996. 10.1136/gut.29.7.990 PubMedWeb of Science®Google Scholar 146 Ursing B, Aim T, Barany F et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease. The cooperative Crohn's disease study in Sweden. II. Results. Gastroenterology 1982: 83: 550–562. PubMedWeb of Science®Google Scholar 147 US Department of Health and Human Services, Public Health Services, National Institutes of Health. Oral health of United States adults. The national survey of oral health in U.S. employed adults and seniors: 1985–1986. Washington , DC : NIH publication no. 87–2868, 1987. Google Scholar 148 Van Dyke TE, Dowell VR Jr, Offenbacher S, Snyder W, Hersh T. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 1986: 53: 671–677. PubMedWeb of Science®Google Scholar 149 Van Dyke TE, Lester MA, Shapira L. The role of host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 1993: 64: 792–806. 10.1902/jop.1993.64.8s.792 PubMedWeb of Science®Google Scholar 150 Van Dyke TE, Mouton C, Zinney C, Dowell VR Jr, Arnold RR. The association of the oral microbiota, IgA antibody and neutrophil functional abnormalities with periodontal disease in inflammatory' bowel disease patients. In: RP MacDermott, ed. Inflammatory bowel disease: current status and future approach. Amsterdam : Elsevier Science Publishers (Biomedical Division), 1988: 579–584. Google Scholar 151 Varley EWB. Crohn's disease of the mouth: report of three cases. Oral Surg Oral Med Oral Pathol 1973: 33: 570–578. 10.1016/0030-4220(72)90369-6 PubMedWeb of Science®Google Scholar 152 Varley JL. The skin in patients with Crohn's disease and oral ulcerative colitis. Trans St Johns Hosp Dermatol Soc 1973: 59: 30–34. PubMedGoogle Scholar 153 Wagner RD, Czuprynski CJ. Cytokine mRNA expression in livers of mice infected with Listeria monocytogenes. J Leukoc Biol 1993: 53: 525–531. 10.1002/jlb.53.5.525 CASPubMedWeb of Science®Google Scholar 154 Wantke F, Gotz M, Jarisch R. Dietary treatment of Crohn's disease. Lancet 1994: 343: 113. CASPubMedWeb of Science®Google Scholar 155 Weterman IT. Oral, oesophageal, and gastroduodenal Crohn's disease. In: RN Allan, MRB Keighly, J Alexander-Williams, C Hawkins, ed. Inflammatory bowel diseases. London : Churchill Livingstone, 1990: 319–320. Google Scholar 156 Wiesenfield D, Ferguson MM, Mitchell DN et al. Orofacial granulomatosis – a clinical and pathological analysis. Q J Med 1985: 54: 101–113. PubMedWeb of Science®Google Scholar 157 Williams O, Gonzalo JA, Martinez C, Kroemer G. Coevolution of hosts and microorganisms: an analysis of the involvement of cytokines in host-parasite interactions. Mem (Inst) Oswaldo Cruz 1992: 87 (suppl 5): 11–21. 10.1590/S0074-02761992000900002 PubMedWeb of Science®Google Scholar 158 Williams PM, Greenberg MS. Management of cheilitis granulomatosa. Oral Surg Oral Med Oral Pathol 1991: 72: 436–439. 10.1016/0030-4220(91)90555-Q CASPubMedWeb of Science®Google Scholar 159 Wilson GW, Sisto JM. Orthognathic surgery in patients with Crohn's disease: a review of the pathophysiology and perioperative management. Current therapy. J Oral Maxillofac Surg 1992: 50: 502–505. 10.1016/S0278-2391(10)80324-6 CASPubMedWeb of Science®Google Scholar 160 Winnie R, DeLuke DM. Melkersson-Rosenthal syndrome. Review of literature and case report. Int J Oral Maxillofac Surg 1992: 21: 115–117. 10.1016/S0901-5027(05)80546-6 CASPubMedWeb of Science®Google Scholar 161 Wright JP, Alp MN, Young GO, Tigler-Wybrandi N. Predictors of acute relapse of Crohn's disease (a laboratory and clinical study). Dig Dis Sci 1987: 32: 164–170. 10.1007/BF01297104 CASPubMedWeb of Science®Google Scholar 162 Yoshimura HH, Estes MK, Graham DY. Search for evidence of a viral aetiology for inflammatory bowel disease. Gut 1984: 25: 347–355. 10.1136/gut.25.4.347 PubMedWeb of Science®Google Scholar 163 Zimmer WM, Rogers R, Reeve CM, Sheridan PJ. Orofacial manifestations of Melkersson-Rosenthal syndrome. Oral Surg Oral Med Oral Pathol 1992: 74: 610–619. 10.1016/0030-4220(92)90354-S CASPubMedWeb of Science®Google Scholar 164 Zurier RB. Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 1993: 48: 57–62. 10.1016/0952-3278(93)90010-T CASPubMedWeb of Science®Google Scholar Citing Literature Volume6, Issue1October 1994Pages 101-115 ReferencesRelatedInformation
Publication Year: 1994
Publication Date: 1994-10-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 44
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot